Clinical trial
Pilot Study for the Evaluation of the Efficacy of OnabotulinumtoxinA in High Frequency Migraine
NCT04578782 is registered in ClinicalTrials.gov with IRCCS National Neurological Institute "C. Mondino" Foundation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Study for the Evaluation of the Efficacy of OnabotulinumtoxinA in High Frequency Migraine
- Lead sponsor
- IRCCS National Neurological Institute "C. Mondino" Foundation
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 13, 2018
- Completion date
- May 31, 2020
- Enrollment
- 32 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
migraine